Plain-English translation of NCT06823427 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing a new approach to treating advanced bladder cancer. Researchers want to see whether giving a medication called together with another drug called toripalimab works better than giving alone. Both groups will receive careful monitoring to see how well the treatment works and how safe it is.
Advanced bladder cancer that cannot be surgically removed is a serious condition, and patients need better treatment options. This trial is testing whether combining two medications that work in different ways might help more patients respond to treatment and live longer.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to receive either the combination treatment or the single medication. You will visit the study clinic regularly for physical exams, blood tests, and imaging scans to monitor how well the treatment is working and check for side effects. The study will track your health for at least several months, and you will need to use contraception for 6 months after your last dose of medication.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
China